Pandion Optimization Alliance has acquired Blackmaple Group (BMG), a purchasing organisation focused on independent physician practices and women’s healthcare providers.
The acquisition will position Pandion as the “premier” group purchasing organisation (GPO) dedicated to women’s health across the US, the alliance said.
Go deeper with GlobalData
It is part of Pandion’s strategic plan to expand its footprint and strengthen its service offerings to healthcare organisations across the country.
By incorporating BMG’s specialisation in women’s healthcare, Pandion aims to further enhance its tailored purchasing solutions for speciality providers, supporting their financial and operational objectives.
With the integration of BMG’s 17,000 members, Pandion’s total membership will grow to exceed 57,000.
These new members will gain immediate access to Pandion’s contract portfolio, benefiting from increased purchasing power aimed at delivering greater cost savings.
Pandion Optimization Alliance president and CEO Travis Heider said: “Blackmaple Group has built a powerful network of providers who are deeply committed to improving healthcare – especially in women’s health.
“By joining forces, we are not only expanding our national footprint but also reinforcing our commitment to providing healthcare organisations with greater purchasing power, optimised supply chains, and access to the best medical and surgical products at competitive prices.”
The deal between Pandion and BMG is expected to provide healthcare providers with continued access to cost-saving opportunities and a wider range of high-quality products and services.
BMG’s existing partnerships with suppliers such as Medline Industries, GE, AbbVie, Samsung, and CooperSurgical will remain in place under the agreement.
BMG COO and president Marc Cooper said: “As far as our collaborators and customers are concerned very little will change.
“Members will have the same model, only with the buying power and support of a much larger organisation, and with an even more robust portfolio.”
Last year, Pandion achieved a purchasing volume of $1.9bn and has set a strategic goal to surpass $3bn by 2027.
